Menu
Faced with increased launch pressures and limited HCP access, pharma companies should orchestrate omnichannel promotion to facilitate the delivery of effective treatment to patients who desperately need it. In Pharmeceutical Executive, David Laros details key lessons from bringing a targeted oncology therapy to market for one midsize biotech company.
